Safety Study of Atomoxetine and Cerebrovascular Outcomes

Completed

Phase N/A Results N/A

Summary of Purpose

Using a proprietary insurance health claims database, Eli Lilly and Company has contracted with an external party to conduct a retrospective cohort study of health claims for the time period from 1 January 2003 through 31 December 2006 (with follow-up of patients through 30 June 2007). This study will evaluate the potential association between atomoxetine and cerebrovascular events. In this study, the incidence...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 14 September 2009.

1 Jan 2008 4 Mar 2008 1 Sep 2008 1 Sep 2008 1 Sep 2009 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Observation: Cohort
  • Perspective: Retrospective
  • Sampling: Probability Sample

Contacts

Not available